Target intelligence / Profile preview

Fungal cell cycle

Molecular classification
Enzyme, Kinase, Transcription factor, Cytoskeletal protein, DNA-binding protein
01

Overview

The fungal cell cycle is a highly regulated series of events comprising DNA replication, chromosome segregation, and cytokinesis that allows for fungal growth and reproduction (Berman, 2006). This process is coordinated by central regulatory proteins, primarily cyclin-dependent kinases (CDKs) like Cdc28/Cdk1, which associate with stage-specific cyclins to drive cells through G1, S, G2, and M phases (Enserink & Kolodner, 2010). As a therapeutic target, the fungal cell cycle offers opportunities for selective toxicity by exploiting structural differences in fungal-specific proteins or unique regulatory mechanisms, such as those involved in bud site selection or fungal-specific spindle pole body dynamics (Schuldiner et al., 2005). Clinically used drugs like griseofulvin target the fungal cell cycle by binding to tubulin and disrupting the mitotic spindle, while others like flucytosine interfere with DNA synthesis to induce S-phase arrest (Panda et al., 2005; Vermes et al., 2000). Although many core components are conserved across eukaryotes, the distinct requirements for fungal cytokinesis and the presence of unique fungal cyclins make this biological process a valuable, albeit complex, area for antifungal drug development (Hartwell, 1974; Rusche & Rine, 2010).

Other names
Fungal cell divisionFungal mitotic cycleFungal replication cycleYeast cell cycle
02

Mechanism of action

Inhibition of specific cell cycle components such as microtubules (disrupting the mitotic spindle), DNA polymerases (halting S-phase progression), or regulatory kinases (preventing phase transitions), resulting in cell cycle arrest and inhibition of fungal growth.

03

Biological functions

Cell cycleDNA replicationMitosisCytokinesisCell proliferation
04

Disease associations

Infection
05

Safety considerations

Potential host toxicity due to high conservation of cell cycle machinery (e.g., tubulin and CDKs) between fungi and humansTeratogenicity (risk of interfering with human embryonic cell division)Rapid development of drug resistance through mutations in specific target proteins like beta-tubulin
06

Interacting drugs

Griseofulvin

5 more in the full profile.

07

Biomarkers

DNA content (ploidy)Mitotic indexCdk1 phosphorylation stateCyclin expression levelsSeptin ring formation

Beyond the preview

Go deeper on Fungal cell cycle.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal cell cycle.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call